Triamterene structure
|
Common Name | Triamterene | ||
|---|---|---|---|---|
| CAS Number | 396-01-0 | Molecular Weight | 253.26300 | |
| Density | 1.502 g/cm3 | Boiling Point | 573.4ºC at 760 mmHg | |
| Molecular Formula | C12H11N7 | Melting Point | 316°C | |
| MSDS | Chinese USA | Flash Point | 11 °C | |
| Symbol |
GHS07 |
Signal Word | Warning | |
Use of TriamtereneTriamterene blocks epithelial Na+ channel (ENaC) in a voltage-dependent manner, which used as a mild diuretic.Target: Sodium ChannelTriamterene blocked rENaC in a voltage-dependent manner, and was 100-fold less potent than amiloride at pH 7.5. At -90 mV and -40 mV, the IC50 values were 5 microM and 10 microM, respectively. The blockage by triamterene, which is a weak base with a pKa of 6.2, was dependent on the extracellular pH. The IC50 was 1 microM at pH 6.5 and only 17 microM at pH 8.5 [1]. Triamterene (TA) is partly eliminated by a first-pass-effect. The main metabolite of TA is OH-TA-ester, which is pharmacologically active [2]. |
| Name | 2,4,7-Triamino-6-Phenylpteridine |
|---|---|
| Synonym | More Synonyms |
| Description | Triamterene blocks epithelial Na+ channel (ENaC) in a voltage-dependent manner, which used as a mild diuretic.Target: Sodium ChannelTriamterene blocked rENaC in a voltage-dependent manner, and was 100-fold less potent than amiloride at pH 7.5. At -90 mV and -40 mV, the IC50 values were 5 microM and 10 microM, respectively. The blockage by triamterene, which is a weak base with a pKa of 6.2, was dependent on the extracellular pH. The IC50 was 1 microM at pH 6.5 and only 17 microM at pH 8.5 [1]. Triamterene (TA) is partly eliminated by a first-pass-effect. The main metabolite of TA is OH-TA-ester, which is pharmacologically active [2]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.502 g/cm3 |
|---|---|
| Boiling Point | 573.4ºC at 760 mmHg |
| Melting Point | 316°C |
| Molecular Formula | C12H11N7 |
| Molecular Weight | 253.26300 |
| Flash Point | 11 °C |
| Exact Mass | 253.10800 |
| PSA | 129.62000 |
| LogP | 2.57700 |
| InChIKey | FNYLWPVRPXGIIP-UHFFFAOYSA-N |
| SMILES | Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1 |
| Storage condition | 2-8°C |
| Water Solubility | <0.1 G/100 ML AT 20 ºC |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302-H315-H319-H335 |
| Precautionary Statements | P301 + P312 + P330-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
| Hazard Codes | Xn:Harmful; |
| Risk Phrases | R22;R36/37/38 |
| Safety Phrases | S26-S36/37/39-S45-S33-S24-S16-S7 |
| RIDADR | 2811 |
| WGK Germany | 3 |
| RTECS | UO3470000 |
| Packaging Group | III |
| Hazard Class | 6.1(b) |
| HS Code | 2933990090 |
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
[Clinical strategies for prevention of drug-induced urinary calculi].
Clin. Calcium 21(10) , 1457-63, (2011) Drug-induced urinary calculi, although they account for only 1-2% of urinary calculi, deserve consideration because most of them are preventable. In the drug-containing calculi resulting from the crys... |
|
|
Bioavailability study of triamterene and xipamide using urinary pharmacokinetic data following single oral dose of each drug or their combination.
J. Pharm. Biomed. Anal. 61 , 78-85, (2012) An efficient chromatographic method for the simultaneous determination of triamterene (TRI) and xipamide (XIP) in urine samples, based on high performance liquid chromatography with photodiode array d... |
|
|
Spectrophotometric and spectrodensitometric determination of triamterene and xipamide in pure form and in pharmaceutical formulation.
Drug Test. Anal. 2(3) , 113-21, (2010) Sensitive and validated UV-spectrophotometric, chemometric and TLC-densitometric methods were developed for determination of triamterene (TRM) and xipamide (XIP) in their binary mixture, formulated fo... |
| Triamterene |
| MFCD00006708 |
| 6-Phenylpteridine-2,4,7-triamine |
| 2,4,7-Triamino-6-phenylpteridine,6-Phenyl-2,4,7-pteridinetriamine |
| EINECS 206-904-3 |
| 2,4,7-Triamino-6-phenylpteridine 6-Phenyl-2,4,7-pteridinetriamine |